HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,393-1,404 of 4,505
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

Official study title

Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center

This study is no longer accepting new participants.

Multiple locations, including Irvine
SchizophreniaObservational studyAges 12–30
Countries
United States, Australia, Canada, + 10 others
Sponsor
Brigham and Women's Hospital
Drug study icon
CompletedNCT00878462

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable people with a Psychotic Disorder (P07010)(COMPLETED)

Official study title

A Randomized, Crossover Study Evaluating the Acceptability of Unflavored Asenapine and Raspberry Flavored Asenapine in Stable Subjects With A Psychotic Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00526877

Long-acting Risperidone for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Taipei
SchizophreniaMedication studyAges 18+
Countries
Taiwan
Sponsor
Johnson & Johnson Taiwan Ltd
Drug study icon
CompletedNCT02983188

Berberine as Adjuvant Treatment for Schizophrenia Patients

Official study title

A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders

This study has finished and is no longer accepting participants.

In Tuenmen
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
The University of Hong Kong
Behavioral study icon
CompletedNCT04949542

Bolster: Caregiver App to Reduce Duration of Untreated Psychosis

Official study title

Development and Testing of a Caregiver-facing Mobile Health Intervention to Reduce Duration of Untreated Psychosis

This study has finished and is no longer accepting participants.

In Seattle
SchizophreniaBehavioural studyAges 18–80
Countries
United States
Sponsor
University of Washington
Drug study icon
Active Not RecruitingNCT05824728

AGB101 for Schizophrenia

Official study title

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

This study is no longer accepting new participants.

In Baltimore
SchizophreniaMedication studyAges 40–85
Countries
United States
Sponsor
Johns Hopkins University
Behavioral study icon
UnknownNCT05455593

Effectiveness of the Combination of Water Aerobics and Metacognitive Training

Official study title

Efficacy of the Combination of Water Aerobics and Metacognitive Training (MCT) on Psychological and Physical Health Variables and Their Relationship With SP1 and SP4 Biomarkers in People With Psychosis

Current recruitment status is unconfirmed.

In Sant Boi de Llobregat
SchizophreniaBehavioural studyAges 18–55
Countries
Spain
Sponsor
Fundació Sant Joan de Déu
Drug study icon
CompletedNCT03649815

Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum

Official study title

Testing the Feasibility and Outcomes of a Digital Health Support for Individuals With Schizophrenia Spectrum Mental Illnesses

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaInterventional studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Other study type icon
UnknownNCT06314204

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms

Official study title

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms : Multicenter Comparative Observational Study

Current recruitment status is unconfirmed.

In Neuilly-sur-Marne
SchizophreniaObservational studyAges 18+
Countries
France
Sponsor
Centre hospitalier de Ville-Evrard, France
Behavioral study icon
CompletedNCT03955549

Insight Enhancement Program vs. Metacognitive Training for Psychosis in people with Schizophrenia: A Three-Armed Comparative Controlled study

Official study title

Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Ţalkhā
SchizophreniaMedication studyAges 18–65
Countries
Egypt
Sponsor
Agiad Psychiatry Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.